Kurtkaya-Yapicier, O. Et Al. 2003. The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?. BMC Clinical Pathology , vol.3 , 1-8.

Kurtkaya-Yapicier, O., Gencosmanoglu, R., Avsar, E., Bakirci, N., Tozun, N., & Sav, A., (2003). The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?. BMC Clinical Pathology , vol.3, 1-8.

Kurtkaya-Yapicier, O Et Al. "The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?," BMC Clinical Pathology , vol.3, 1-8, 2003

Kurtkaya-Yapicier, O Et Al. "The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?." BMC Clinical Pathology , vol.3, pp.1-8, 2003

Kurtkaya-Yapicier, O. Et Al. (2003) . "The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?." BMC Clinical Pathology , vol.3, pp.1-8.

@article{article, author={O Kurtkaya-Yapicier Et Al. }, title={The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?}, journal={BMC Clinical Pathology}, year=2003, pages={1-8} }